-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Artificial Intelligence (AI) and Machine Learning (ML) in the Context of Anticoagulation Management

Program: Special-Interest Sessions
Session: Systems-Based Hematology Education and Networking Session: Anticoagulation Stewardship and AI-Assisted Management
Hematology Disease Topics & Pathways:
Anticoagulant Drugs, Artificial intelligence (AI), Clinical Practice (Health Services and Quality), Workforce, Treatment Considerations, Non-Biological therapies, Technology and Procedures, Machine learning
Sunday, December 8, 2024, 4:30 PM-6:30 PM

Damon E. Houghton, MD, MS

Mayo Clinic Rochester, Rochester, MN

Disclosures: Houghton: Veralox: Research Funding; Bayer: Research Funding.

See more of: Systems-Based Hematology Education and Networking Session: Anticoagulation Stewardship and AI-Assisted Management
See more of: Special-Interest Sessions
<< Previous Presentation | Next Presentation